Rabenosyn-5 Inhibitors
Chemical inhibitors of Rabenosyn-5 disrupt its function primarily by interfering with the endocytic pathways and related cellular processes in which this protein is involved. Wortmannin and LY294002 are chemical inhibitors that target the phosphoinositide 3-kinases (PI3K), which are crucial for initiating endosome formation. By inhibiting PI3K, these chemicals can disrupt the early stages of endosome formation, thereby inhibiting Rabenosyn-5's function in the endocytic trafficking process. 3-Methyladenine serves as another inhibitor in this category by also targeting PI3K and thereby impacting the autophagy pathway, which shares molecular machinery with endocytosis. This inhibition can negatively affect Rabenosyn-5's role in the endocytic pathway.
The function of Rabenosyn-5 is further inhibited by chemicals like Dynasore, Dyngo-4a, and MiTMAB, which target the GTPase activity of dynamin. Dynamin is critical for the "pinching off" process of clathrin-coated vesicles from the plasma membrane, a step in which Rabenosyn-5 is implicated. By inhibiting dynamin, these chemicals can prevent the successful formation of endocytic vesicles, leading to the inhibition of Rabenosyn-5's function in this process. Similarly, Pitstop 2 and Chlorpromazine obstruct clathrin-mediated endocytosis, with Pitstop 2 specifically inhibiting the interaction of clathrin with its accessory proteins, and Chlorpromazine blocking the formation of clathrin-coated pits. Another inhibitor, Ikarugamycin, specifically inhibits clathrin-dependent endocytosis, thus impacting Rabenosyn-5's role in vesicle formation. Endosidin 9 targets the ESCRT machinery, which is important for the maturation and sorting of endosomes, inhibiting a later stage of the endocytic process where Rabenosyn-5 is active. Lastly, Phenylarsine oxide (PAO) inhibits phosphatases. These enzymes modulate phosphorylation states of proteins involved in endocytosis, and their inhibition by PAO can interfere with the regulatory mechanisms of endocytic trafficking, consequently inhibiting Rabenosyn-5's function in this cellular process.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a steroidal metabolite of the fungi Penicillium funiculosum and is a potent and irreversible inhibitor of phosphoinositide 3-kinases (PI3K). Rabenosyn-5 is involved in endocytic trafficking and PI3K activity is critical for endosome formation. Inhibition of PI3K by Wortmannin could disrupt endosome formation, thereby impairing Rabenosyn-5 function in endocytic trafficking. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a synthetic molecule that functions as a selective inhibitor of PI3Ks. Similar to Wortmannin, LY294002's inhibition of PI3K would disrupt endosome formation and function, hence impairing Rabenosyn-5's role in the endocytic pathway. | ||||||
Autophagy Inhibitor, 3-MA | 5142-23-4 | sc-205596 sc-205596A | 50 mg 500 mg | $65.00 $261.00 | 113 | |
3-Methyladenine is known to inhibit autophagy through its action on PI3K. By inhibiting PI3K, it would similarly interfere with the endocytic pathways and endosome formation, impacting Rabenosyn-5's function. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a non-competitive inhibitor of the GTPase activity of dynamin, which is crucial for clathrin-mediated endocytosis. By inhibiting dynamin, Dynasore can impair clathrin-mediated endocytosis, a process in which Rabenosyn-5 is implicated. | ||||||
Hydroxy-Dynasore | 1256493-34-1 | sc-364678 | 10 mg | $255.00 | ||
Dyngo-4a inhibits dynamin, similar to Dynasore. Through its action on dynamin, Dyngo-4a would inhibit clathrin-mediated endocytosis, thereby potentially impairing the function of Rabenosyn-5 in this pathway. | ||||||
Pitstop 2 | 1419320-73-2 | sc-507418 | 10 mg | $360.00 | ||
Pitstop 2 is an inhibitor of clathrin terminal domain interaction with its accessory proteins. By inhibiting clathrin function, it would prevent the formation of clathrin-coated pits and vesicles, thus indirectly inhibiting Rabenosyn-5's function in endocytosis. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Chlorpromazine is a cationic amphiphilic drug that has been shown to block clathrin-mediated endocytosis. By inhibiting this process, Chlorpromazine would disrupt Rabenosyn-5's role in endocytic vesicle formation. | ||||||
Ikarugamycin | 36531-78-9 | sc-202179 | 500 µg | $189.00 | 4 | |
Ikarugamycin is a natural product that inhibits clathrin-dependent endocytosis. By blocking this pathway, Ikarugamycin would impair Rabenosyn-5's function in the formation of clathrin-coated vesicles and their subsequent trafficking. | ||||||
Phenylarsine oxide | 637-03-6 | sc-3521 | 250 mg | $41.00 | 4 | |
Phenylarsine oxide (PAO) is an inhibitor of tyrosine phosphatases, and it can indirectly affect endocytosis by inhibiting dephosphorylation events necessary for the progression of endocytic vesicles. This inhibition would impede Rabenosyn-5's associated activities in endocytic trafficking. | ||||||